MarketPulse

TP53 Y220C mutation

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

PMV Pharma Names Finance Veteran Stelzer as New Board Chair

PMV Pharmaceuticals appoints Laurie Stelzer as Board Chair effective June 2026, succeeding Rich Heyman. Transition occurs amid ongoing clinical trials for ovarian cancer treatment.
PMVPNew Drug Applicationprecision oncology
GlobeNewswire Inc.GlobeNewswire Inc.··Pmv Pharmaceuticals, Inc.

PMV Pharma's Rezatapopt Shows Promise, But Cash Clock Ticks Toward 2027

PMV Pharmaceuticals reports 50% response rate for ovarian cancer drug rezatapopt, but faces funding pressure with cash runway extending only to Q2 2027.
PMVPclinical trial resultsorphan drug designation